Evidence map›Paper›PMID 18395902›Full record

Trial reportWorld journal of gastroenterology2008

Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults.

Riina-A Kekkonen, Netta Lummela, Heli Karjalainen, Sinikka Latvala, Soile Tynkkynen, Salme Jarvenpaa, Hannu Kautiainen, Ilkka Julkunen, Heikki Vapaatalo, Riitta Korpela

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in World journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01479543 (Colonization, Safety, Tolerance, and Effects of Three Probiotic Strains on the Immune System of Healthy Adults), which is not on this map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01479543 nacompletednot on this mapstarted 2011, after this paper: background citation

Colonization, Safety, Tolerance, and Effects of Three Probiotic Strains on the Immune System of Healthy Adults

TypeinterventionalSponsorHero Institute for Infant NutritionRan2011 to 2012Enrolled103ConditionsConditions Influencing Health StatusArmsProbiotic CNCM I-4034, Probiotic CNCM I-4035, Probiotic CNCM I-4036, Probiotics CNCM I-4035 and CNCM I-4036, Placebo
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 214 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. World journal of diabetes · 2025
    Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Riina-A KekkonenUniversity of Helsinki, Institute of Biomedicine, Pharmacology, PO Box 63, 00014 Helsinki, Finland.
Netta Lummela
Heli Karjalainen
Sinikka Latvala
Soile Tynkkynen
Salme Jarvenpaa
Hannu Kautiainen
Ilkka Julkunen
Heikki Vapaatalo
Riitta Korpela
University of Pisa · ITValio (Finland) · FIInstitute for Molecular Medicine Finland · FIUniversity of Helsinki · FIVetcare (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the effects of three potentially anti-inflammatory probiotic bacteria from three different genera on immune variables in healthy adults in a clinical setting based on previous in vitro characterization of cytokine responses.

methodsA total of 62 volunteers participated in this randomized, double-blind and placebo-controlled parallel group intervention study. The volunteers were randomized to receive a milk-based drink containing either Lactobacillus rhamnosus GG (LGG), Bifidobacterium animalis ssp. lactis Bb12 (Bb12), or Propionibacterium freudenreichii ssp. shermanii JS (PJS) or a placebo drink for 3 wk. Venous blood and saliva samples were taken at baseline and on d 1, 7 and 21. Fecal samples were collected at baseline and at the end of intervention.

resultsThe serum hsCRP expressed as the median AUC(0-21) (minus baseline) was 0.018 mg/L in the placebo group, -0.240 mg/L in the LGG group, 0.090 mg/L in the Bb12 group and -0.085 mg/L in the PJS group (P = 0.014). In vitro production of TNF-alpha from in vitro cultured peripheral blood mononuclear cells (PBMC) was significantly lower in subjects receiving LGG vs placebo. IL-2 production from PBMC in the Bb12 group was significantly lower compared with the other groups.

conclusionIn conclusion, probiotic bacteria have strain-specific anti-inflammatory effects in healthy adults.

Indexed as

AdultAnti-Inflammatory AgentsArea Under CurveBifidobacteriumC-Reactive ProteinDouble-Blind MethodFemaleHumansImmunoglobulinsLacticaseibacillus rhamnosusLeukocytes, MononuclearMaleMiddle AgedPlacebosProbioticsPropionibacteriumAnti-Inflammatory AgentsC-Reactive ProteinImmunoglobulinsPlacebos

Identifiers

PMID18395902
PMCPMC2701523
OpenAlexW2093398546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.